SERUR : Etude sérologique COVID-19 (Anti-SARS CoV 2) du Personnel de l'Université de Reims Champagne-Ardenne
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 389
- Locations
- 1
- Primary Endpoint
- Prevalence of IgG and IgM anti-SARS CoV2 antibodies
Study Overview
Brief Summary
This study was designed to determine, in a screening situation within the framework of university preventive medicine, the prevalence of positive anti-SARS-Cov 2 serology among the staff of the University of Reims Champagne-Ardenne. The serological tests chosen will allow systematic detection of anti-SARS-CoV-2 IgM and anti-SARS-Cov-2 IgG to assess the moment of potential contamination prior to resumption of occupational activity.
Detailed Description
Objective:
This study was designed to determine, in a screening situation within the framework of university preventive medicine, the prevalence of positive anti-SARS-Cov 2 serology among the staff of the University of Reims Champagne-Ardenne. The serological tests chosen will allow systematic detection of anti-SARS-CoV-2 IgM and anti-SARS-Cov-2 IgG to assess the moment of potential contamination prior to resumption of occupational activity.
Type of study:
This is a prevalence study, a single-center cross-sectional study published on the human person.
Population:
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Screening
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Major volunteers from the Staff of the University of Reims Champagne-Ardenne (>18 years old)
Exclusion Criteria
- •(Non Inclusion):
- •persons who do not desire to participate
Outcomes
Primary Outcomes
Prevalence of IgG and IgM anti-SARS CoV2 antibodies
Time Frame: Inclusion time was ½ day, time for blood sampling
Anti-SARS-Cov2 seroprevalence measured in blood sample collected at Day 0.
Secondary Outcomes
No secondary outcomes reported